|Description||develops influenza vaccines|
|Series A, 5/07 |
Bay City Capital
Vivaldi Biosciences Inc. develops influenza vaccines and therapeutics for seasonal and pandemic influenza through a small molecule program targeting the NS1 protein of influenza. The company was founded in 2006 and is based in San Francisco, California.